for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Cyclo Therapeutics Reports Positive Feedback From EMA On Trial Design For Niemann-Pick Disease Type C

May 18 (Reuters) - Ctd Holdings Inc:

* CYCLO THERAPEUTICS ANNOUNCES POSITIVE FEEDBACK FROM EUROPEAN MEDICINES AGENCY ON ITS PIVOTAL TRIAL DESIGN FOR TRAPPSOL CYCLO FOR NIEMANN-PICK DISEASE TYPE C Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up